Evolent Health (EVH) Preferred Stock Liabilities (2014 - 2025)

Evolent Health has reported Preferred Stock Liabilities for 4 years, with the latest figure at $228.8 million in Q2 2025.

• On a quarterly basis, Preferred Stock Liabilities rose 24.21% year-over-year to $228.8 million in Q2 2025; TTM through Jun 2025 was $228.8 million, a 24.21% increase from a year earlier, with the FY2024 full-year figure at $190.2 million, up 6.58% from the prior year.
• Preferred Stock Liabilities was $228.8 million for Q2 2025 at Evolent Health, up from $193.2 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $228.8 million in Q2 2025, with the low at $170.6 million in Q1 2023.
• Average Preferred Stock Liabilities over 3 years is $186.2 million, with a median of $182.8 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Preferred Stock Liabilities rose 6.25% in 2024, then climbed 24.21% in 2025.
• Over 3 years, Preferred Stock Liabilities stood at $178.4 million in 2023, then gained by 6.58% to $190.2 million in 2024, then climbed by 20.31% to $228.8 million in 2025.
• The last three Preferred Stock Liabilities figures came in at $228.8 million (Q2 2025), $193.2 million (Q1 2025), and $190.2 million (Q4 2024), per Business Quant data.